Intestinal Cell News Volume 9.31 | Aug 25 2023

    0
    10







    2023-08-25 | ICN 9.30


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.31 – 25 August, 2023
    TOP STORY

    Phosphoproteomics of Patient-Derived Xenografts Identifies Targets and Markers Associated with Sensitivity and Resistance to EGFR Blockade in Colorectal Cancer

    Mass spectrometry–based proteomics and phosphoproteomics were performed on 30 genomically and pharmacologically characterized metastatic colorectal cancer patient–derived xenografts to investigate the molecular basis of response to epidermal growth factor receptor (EGFR) blockade.
    [Science Translational Medicine]

    Abstract
    Immunofluorescence image of adult stem cell-derived intestinal organoids.
    PUBLICATIONSRanked by the impact factor of the journal

    DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer

    Analysis of the genome-wide methylation landscape of peripheral blood mononuclear cells from colorectal cancer (CRC) patients and healthy controls by microarray, pyrosequencing, and targeted bisulfite sequencing revealed five DNA methylation markers for CRC diagnosis, especially early-stage CRC.
    [Cancer Research]

    Abstract

    Hypoxia Induces a Glycolytic Complex in Intestinal Epithelial Cells Independent of HIF-1-Driven Glycolytic Gene Expression

    Researchers observed that intestinal epithelial cells treated with inhibitors of transcription or translation and human platelets maintained the capacity for hypoxia-induced glycolysis, a finding that suggested the involvement of a nontranscriptional component to the metabolic switch to a highly glycolytic phenotype.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Ferroptosis Triggered by STAT1- IRF1-ACSL4 Pathway Was Involved in Radiation-Induced Intestinal Injury

    Investigators demonstrated that ferroptosis played a critical role in radiation-induced intestinal injury (RIII) occurrence. The RNA sequencing analysis strongly hinted ferroptosis was involved in RIII mice.
    [Redox Biology]

    Full ArticleGraphical Abstract

    Paired Microbiome and Metabolome Analyses Associate Bile Acid Changes with Colorectal Cancer Progression

    Using multi-omics studies on genetically controlled cohorts of mice, investigators identified diet as the major driver of microbial and metabolomic differences, with reductions in α diversity and widespread changes in cecal metabolites seen in high-fat diet-fed mice.
    [Cell Reports]

    Full ArticleGraphical Abstract

    A HER2-Targeting Antibody-MMAE Conjugate RC48 Sensitizes Immunotherapy in HER2-Positive Colon Cancer by Triggering the cGAS-STING Pathway

    Researchers found that human epidermal growth factor receptor 2 (HER2) was present in a portion of colon cancer patients, raising the possibility of using anti-HER2 therapy. In vitro studies using colon cancer cell lines showed that RC48 effectively impeded the proliferation of HER2-positive cells.
    [Cell Death & Disease]

    Full Article

    OTULIN Protects the Intestinal Epithelium from Apoptosis during Inflammation and Infection

    Scientists showed that mice with intestinal epithelial cell (IEC)-specific OTULIN deficiency exhibited increased susceptibility to experimental colitis and were highly sensitive to TNF toxicity, due to excessive apoptosis of OTULIN deficient IECs.
    [Cell Death & Disease]

    Full Article

    ASCL2 Induces an Immune Excluded Microenvironment by Activating Cancer-Associated Fibroblasts in Microsatellite Stable Colorectal Cancer

    Researchers reported two distinct expression patterns of achaete-scute homolog 2 (ASCL2) in proficient mismatch repair or microsatellite stable (pMMR/MSS) and dMMR/MSI-H colorectal cancers (CRCs). ASCL2 was overexpressed in pMMR/MSS CRCs and maintained a stemness phenotype.
    [Oncogene]

    Full Article

    Association of CDX2 and Mucin Expression with Chemotherapeutic Benefits in Patients with Stage II/III Gastric Cancer

    Scientists assessed the ability of caudal-type homeobox transcription factor 2 (CDX2) and mucin markers to predict prognosis and fluorouracil-based adjuvant chemotherapy benefits.
    [Cancer Medicine]

    Full Article
    Explore tools and resources for your return to the lab
    REVIEWS

    A Spotlight on Intestinal Permeability and Inflammatory Bowel Diseases

    The authors first introduce the basic organization of the intestinal barrier and then summarize different methods to assess barrier function in vivo and ex vivo. Finally, they provide an in-depth overview of the relevance of intestinal barrier dysfunction in inflammatory bowel diseases.
    [Expert Review Of Gastroenterology & Hepatology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Actimed Therapeutics Secures Additional £4.75M Funding in Series A Extension Round, Almost Doubling Series A Proceeds

    The funding will be used for the continued development of the company and will ensure that preparations remain on track for the global Phase IIb/III IMPACT clinical development program evaluating its lead asset, S-pindolol benzoate in treating cachexia associated with non-small cell lung cancer and colorectal cancer.
    [Actimed Therapeutics, Ltd.]

    Press Release

    Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland

    Mainz Biomed NV announces the commercial launch of ColoAlert® in Poland, made possible through a strategic collaboration with testDNA. The partnership marks another significant step forward in providing new and innovative testing options to underserved populations in the battle against colorectal cancer.
    [Mainz Biomed NV]

    Press Release
    FEATURED EVENT

    The Human Microbiome

    September 20 – 23, 2023
    EMBL Heidelberg and Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Molecular Biology of Colorectal Cancer

    SciLifeLab – Solna, Sweden

    Professor – Clinical Pediatrics

    University of South California – Los Angeles, California, United States

    PhD Studentship – Microbial Metabolites on Colorectal Cancer Cell Growth

    Coventry University – Coventry, England, United Kingdom

    Research Associate – Recombinant Protein

    Creative Biolabs – New York, New York, United States

    Postdoctoral Researcher – Molecular Biology of Colorectal Cancer

    Uppsala University – Uppsala, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter